Patents by Inventor David M. BRESSE

David M. BRESSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM OF 3-METHYLSULFONYLPROPIONITRILE
    Publication number: 20140330037
    Abstract: The present invention relates to processes for preparing 3-methylsulfonylpropionitrile. The processes provide a good yield and a good purity of the final product and provide a controllable reaction. The present invention also relates to a crystalline form of 3-methylsulfonylpropionitrile having X-ray diffraction peaks at 13.9±0.1, 19.2±0.1, 20.0±0.1, 22.5±0.1, 23.2±0.1, 25.7±0.1, 28.1±0.1, 29.9±0.1, and 30.6±0.1 degrees 2?, and wherein the most intense peak is the peak at 13.9±0.1 degrees 2?.
    Type: Application
    Filed: July 18, 2014
    Publication date: November 6, 2014
    Inventors: Joseph P. ST. LAURENT, Gerald S. JONES, David M. BRESSE
  • Process for preparing 3-methylsulfonylpropionitrile
    Patent number: 8802885
    Abstract: The present invention relates to processes for preparing 3-methylsulfonylpropionitrile. The processes provide a good yield and a good purity of the final product and provide a controllable reaction. The present invention also relates to a crystalline form of 3-methylsulfonylpropionitrile having X-ray diffraction peaks at 13.9±0.1, 19.2±0.1, 20.0±0.1, 22.5±0.1, 23.2±0.1, 25.7±0.1, 28.1±0.1, 29.9±0.1, and 30.6±0.1 degrees 2?, and wherein the most intense peak is the peak at 13.9±0.1 degrees 2?.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: August 12, 2014
    Assignee: Olatec Industries LLC
    Inventors: Joseph P. St. Laurent, Gerald S. Jones, David M. Bresse
  • PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN
    Publication number: 20130324603
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: June 4, 2013
    Publication date: December 5, 2013
    Inventors: Joseph ST. LAURENT, Gerald S. JONES, David M. BRESSE
  • PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN
    Publication number: 20130324601
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a ?-(arylsulfonyl)alkylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ?-(arylsulfonyl)alkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: June 4, 2013
    Publication date: December 5, 2013
    Inventors: Joseph ST. LAURENT, Gerald S. JONES, David M. BRESSE